Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $360 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on Humana (NYSE:HUM) and maintained a price target of $360.
June 12, 2024 | 4:37 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has reiterated a Neutral rating on Humana and maintained a price target of $360. This suggests that the analyst does not expect significant short-term movement in the stock price.
The reiteration of a Neutral rating and the maintenance of the $360 price target indicate that the analyst does not foresee significant changes in Humana's stock price in the short term. This suggests a stable outlook for the company.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100